Allergan Snags Rhythm’s Diabetes-Related GI Drug for $200M

Rhythm Pharmaceuticals is selling a stomach drug for $200 million to Dublin-based Allergan, a deal that has been in the works since 2014. Allergan is acquiring Motus Therapeutics (formerly Rhythm Heal…